Warning Letters Special Report: Pandemic Drove Focused Inspections, Alternative Approaches

In the first part of our in-depth series, the Pink Sheet outlines how 2022 warning letters reflected agency’s efforts to overcome COVID-19 travel restrictions. As pandemic abates, a new, less inspection-intensive normal could emerge.

Warning Letters Special Report
How the FDA found so many problems with so few inspections • Source: Shutterstock

More from Manufacturing

More from Compliance